Performance of focus ELISA tests for HSV-1 and HSV-2 antibodies among university students with no history of genital herpes

Sexually Transmitted Diseases

Volumn 34, Issue 9, 2007, Pages 681-685

  Mark, Hayley D ^a   Nanda, Joy P ^b   Roberts, Jessica ^a   Rompalo, Anne ^c   Melendez, Johan H ^c   Zenilman, Jonathan ^c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF NURSING   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY;

ADULT; ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENITAL HERPES; HERPES SIMPLEX VIRUS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; MALE; PERFORMANCE; POPULATION; PREDICTOR VARIABLE; PREVALENCE; SCREENING; SEROPREVALENCE; SERUM; UNIVERSITY STUDENT; WESTERN BLOTTING;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HERPES GENITALIS; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; MALE; MARYLAND; PREDICTIVE VALUE OF TESTS; QUESTIONNAIRES; SENSITIVITY AND SPECIFICITY; SEROEPIDEMIOLOGIC STUDIES; STUDENTS;

EID: 34548190328     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.olq.0000258307.18831.f0     Document Type: Article

References (30)

1. Xu F, Sternberg MR, Kottiri BJ, et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA 2006; 296:964-973.
2. Freeman EE, Weiss HA, Glynn JR, et al. Herpes simplex virus 2 infection increases HIV acquisition in men and women: Systemic review and meta-analysis of longitudinal studies. AIDS 2006; 20:73-83.
3. Brugha R, Keersmaekers K, Renton A, et al. Genital herpes infection: A review. Int J Epidemiol 1997; 26:698-709.
4. Schillinger JA, Xu F, Sternberg MR, et al. National seroprevalence and trends in herpes simplex virus type 1 in the United States, 1976-1994. Sex Transm Dis 2004; 31:753-760.
5. Lamey PJ, Hyland PL. Changing epidemiology of herpes simplex virus type 1 infections. Herpes 1999; 6:20-24.
6. Coyle PV, O'Neill HJ, Wyatt DE, et al. Emergence of herpes simplex type 1 as the main cause of recurrent genital ulcerative disease in women in Northern Ireland. J Clin Virol 2003; 27:22-29.
7. Nieuwenhuis RF, van Doorum GJ, Mulder PG, et al. Importance of herpes simplex virus type-1 (HSV-1) in primary genital herpes. Acta Derm Venereol 2006; 86:129-134.
8. Wald A, Krantz R, Selke S, et al. Knowledge of partners' genital herpes protects against herpes simplex virus type 2 acquisition. J Infect Dis 2006; 194:42-25.
9. Corey L, Handsfield HH. Genital herpes and public health: Addressing a global problem. JAMA 2000; 283:791-794.
10. Brown ZA. HSV-2 specific serology should be offered routinely to antenatal patients. Rev Med Virol 2000; 10:141-144.
11. Brugha R, Brown D, Meheus A, et al. Should we be screening for asymptomatic HSV infections? Sex Transm Infect 1999; 75:142-144.
12. Wilkinson D, Barton S, Cowen F. HSV-2 specific serology should not be offered routinely to antenatal patients. Rev Med Virol 2000; 10:145-153.
13. Mindel A, Taylor J. Debate: The argument against. Should every STD clinic patient be considered for type-specific serological screening for HSV? Herpes 2002; 9:35-37.
14. Golden MR, Morrow RA, Swenson P, et al. Herpes simplex virus type 2 (HSV-2) western blot confirmatory testing among men testing positive for HSV-2 using the focus enzyme-linked immunosorbent assay in sexually transmitted disease clinic. Sex Transm Dis 2005; 32:771-777.
15. Handsfield HH, Stone KM, Wasserheit JN. Prevention agenda for genital herpes. Sex Transm Dis 1999; 26:228-231.
16. Ashley-Morrow R, Brown ZA. Common use of inaccurate antibody assays to identify infection status with herpes simplex virus type 2. Am J Obstet Gynecol 2005; 193:261-262.
17. Ashley RL, Eagleton M. Type specific antibodies to HSV-1 and HSV-2: Review of methodology. Herpes 1998; 5:33-38.
18. Prince HE, Ernst CE, Hogrefe WR. Evaluation of an enzyme immunoassay for measuring herpes simplex virus (HSV) type 1 and HSV type 2 specific IgG antibodies. J Clin Lab Anal 2000; 14:14-16.
19. Turner KR, Wong E, Kent CK, et al. Serologic herpes testing in the real world. Validation of new type-specific serologic herpes simplex virus tests in a public health laboratory. Sex Transm Dis 2002; 29:422-425.
20. Ashley-Morrow R, Nollkamper J, Robinson NJ, et al. Performance of Focus ELISA tests for herpes simplex virus type 1 (HSV-1) and HSV-2 antibodies among women in ten diverse geographical locations. Clin Microbiol Infect 2004; 10:530-536.
21. Hoegrefe W, Su X, Song J, et al. Detection of herpes simplex virus type 2 specific immunoglobulin G antibodies in African sera by using recombinant gG2, western blotting and gG2 inhibition. J Clin Microbiol 2002; 40:3635-3640.
22. Ngo TH, Laeyendecker OB, La H, et al. Comparison between Sure-Vue Rapid HSV-2 Test, Focus and Kalon enzyme-linked assays (ELISA) for antibodies to herpes simplex virus type 2 glycoprotein G in a low-risk population using Western Blot as the "Gold Standard". Poster presentation. 2006 National STD Conference, Jacksonville, FL, May 2006.
23. Morrow RA, Friedrich D, Meier A, et al. Use of biokit HSV-2 rapid assay to improve the positive predictive value of Focus HerpeSelect HSV-2 ELISA. BMC Infect Dis 2005; 5:1-7.
24. US Preventive Services Task Force (USPSTF). Screening for genital herpes: Recommendation statement. Rockville, MD: Agency for Healthcare Research and Quality (AHRQ); 2005:11.
25. CDC. STD treatment guidelines, 2006. MMWR 2006; 55:1-94.
26. American College of Obstetricians and Gynecologists. Management of herpes in pregnancy: Clinical management guidelines for obstetrician-gynecologists. Int J Gynaecol Obstet 2000; 68:165-173.
27. Hook EW, Leone P. Time to translate new knowledge into practice: A call for a national genital herpes control program. J Infect Dis 2006; 194:6-7.
28. Brown ZA, Gardella C, Wald A, et al. Genital herpes complicating pregnancy. Obstet Gynecol 2005; 106:845-856.
29. Laeyendecker O, Henson C, Gray RH, et al. Performance of a commercial, type-specific enzyme lined immunosorbent assay for detection of herpes simplex virus type 2 specific antibodies in Ugandans. J Clin Microbiol 2004; 42:1794-1796.
30. Ashley-Morrow R, Krantz E, Wald A. Time course to seroconversion by HerpeSelect ELISA after acquisition of genital herpes type 1 (HSV-1) or HSV-2. Sex Transm Dis 2003; 30:310-314.